Based in NEW YORK, NY, CANCER RESEARCH INSTITUTE INC operates as a Public Charity. The organization reported $35.5M in revenue, $42.1M in expenses, $129.6M in total assets for fiscal year 2025. Imperigo tracks 227 reported grant relationships connected to this organization totaling approximately $24.7M.
SEE SCHEDULE OCRI IS A NONPROFIT ORGANIZATION DEDICATED TO ADVANCING CANCER IMMUNOTHERAPY THROUGH SCIENTIFIC DISCOVERY AND GLOBAL COLLABORATION. SINCE 1953, CRI HAS FUNDED RESEARCH THAT DEEPENS UNDERSTANDING OF THE IMMUNE SYSTEM AND ITS ROLE IN CANCER, LEADING TO BREAKTHROUGHS SUCH AS CHECKPOINT BLOCKADE AND CELL-BASED THERAPIES. THROUGH INVESTMENTS IN SCIENCE, DATA, AND THE RESEARCH COMMUNITY, CRI WORKS TO TRANSLATE DISCOVERIES INTO EFFECTIVE TREATMENTS FOR PATIENTS.
Showing up to 5 of 227 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $35.5M | $42.1M | $129.6M |
| 2024 | $24.0M | $32.8M | $133.7M |
| 2023 | $32.3M | $38.6M | $138.0M |
| 2022 | $33.7M | $31.3M | $130.4M |
| 2021 | $36.0M | $37.1M | $146.5M |
Between 2021 and 2025, reported annual revenue held roughly steady at around $35.5M, with total assets most recently reported at $129.6M.
Interactive year-over-year charts and full filing details available with membership.
